๐๏ธ Verified NIH Record โข Updated 2024-02-13
A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis (NCT06257589)
A Grounded Theory of Phrenic Nerve Reconstruction for the Treatment of Diaphragm Paralysis - A Biopsychosocial Approach to Surgical Evaluation and Outcomes
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Advanced Reconstructive Surgery Alliance
๐ฉบ Plain-English Summary (8th-Grade Level)
A retrospective chart review to evaluate the safety and efficacy of phrenic nerve reconstruction for diaphragmatic paralysis.
Who can join: Review the eligibility criteria below.
Location: Advanced Reconstructive Surgery Alliance โ Red Bank, New Jersey
Age range: 18 Years to 95 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- Advanced Reconstructive Surgery Alliance โ Red Bank, New Jersey
- Institute for Advanced Reconstruction โ Shrewsbury, New Jersey
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diaphragm Issues
- Reliability of Diaphragm Ultrasound: Intra- and Interrater Analysis โ Toronto, Ontario
- STIMIT Activator 1 IDE Study โ New Haven, Connecticut
Explore by condition: All Diaphragm Issues clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.